RNA Formulation Videos
-
Transforming Nanoparticles By Continuous Manufacturing
9/13/2025
Discover how continuous manufacturing of nanoparticles can improve process efficiency, reduce costs, and increase the quality of the final drug product.
-
A Benchtop System For Lipid Nanoparticle (LNP) Formulation
12/6/2024
Discover the unparalleled flexibility and automation that sets the IJM NanoScaler Pro apart from other lipid nanoparticle systems.
-
Software For Liquid Nanoparticle (LNP) Systems
12/6/2024
Optimize your LNP research with KNAUER's innovative software. Streamline your workflow, overcome challenges, and achieve optimal results with ease.
-
CMC Innovations Worth Watching In The RNA-LNP Space
12/4/2024
Sanofi’s Sumit Luthra shares several of the analytical and manufacturing innovations/improvements he’s watching and waiting for that will improve our knowledge of LNP composition, structure, function, and quality.
-
In What Ways Are We Underestimating LNP Complexity Today?
12/4/2024
As the RNA-LNP space continues to diversify beyond linear mRNA and infectious disease vaccines, Kate Zhang of Hopewell Therapeutics, Sumit Luthra of Sanofi, and Ben Muir of BioNTech each address several misconceptions about LNP composition today and how the rise of novel RNA modalities, more advanced mechanisms of action, and novel lipids are challenging our understanding of/work with LNPs today.
-
The Latest And Greatest Technological Innovations In mRNA-LNP Production
2/10/2025
In this segment, Replicate Biosciences’ Andy Geall, Qian Ruan, & Alex Aust identify the most promising technological and raw material innovations that are influencing the drug substance and drug product production processes at CDMOs.
-
mRNA LNP Scale Up For GMP Vaccine Production
4/14/2022
Explore an overview of the development and scale-up activities needed to develop high quality lipid nanoparticles and progress this saRNA vaccine to the clinic.
-
Polysarcosine-Functionalized LNPs For Therapeutic mRNA Delivery
4/14/2022
Discover how polysarcosine-functionalized lipid nanoparticles are transforming mRNA delivery. Join Dr. Heinrich Haas of BioNTech as he unveils innovative research and its implications for therapeutic breakthroughs.
-
CRISPR Meets LNPs: A New Era In Cell And Gene Therapies
7/8/2025
Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
The Pre-IND "Diaries": What Can mRNA Makers Expect From Early FDA Engagement?
5/10/2024
Nutcracker Therapeutics’ Oreanna Thomas shares her takeaways from a pre-IND meeting for one of the company’s mRNA therapeutic candidates.